As shown in this study, the contribution of a single gene polymorphism ranged from 3.7 to 5%, while the combined effect of all three polymorphisms (MTHFR C, ACTN3 X, and NRF2 C) explained as much as 39% of the interindividual variability in sarcopenia risk. This evidence concerns the gene MTHFR and sarcopenia.